• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC-S 60 REFOBACIN PLUS BO NE CEMENT; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC-S 60 REFOBACIN PLUS BO NE CEMENT; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Improper Chemical Reaction (2952)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/24/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).Customer has indicated that the product will not be returned to zimmer biomet for investigation.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that the cement used for the case started to go hard at 5 minutes.It was during the impaction of the femur that it started going off.The patient was in a couple degrees of extension so even though the femoral component did not fully seat it ended up in 2 degrees of flexion which the surgeon was satisfied with.
 
Manufacturer Narrative
(b)(4).This follow-up report is being filled to relay additional information.The following sections were updated: b5, d1, d4, d5, e1, g1-2, g4, h2, h3, h4, h6, h10.The product was not returned and could not be analyzed.Ttherefore,, the reported event could not be fonfirmed.The review of the device manufacturing quality record indicates that (b)(4) products optipac-s 60 refobacin plus bone cement, reference 4721502084-1, lot number a703a07285 were manufactured on 24 may 2017, the device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.2 similar complaints (including the current complaint) have been recorded for optipac, reference 4721502084-1, batch a703a07285, within one year.With the available information, the exact root cause of the event could not be determined.A summary of the investigation was sent to the complainant conveying zimmer biomet conclusions.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It has reported that the cement used for the case started to go hard at 5 minutes.It was during the impaction of the femur that it started going off.The patient was in a couple degrees of extension so even though the femoral component did not fully seat it ended up in 2 degrees of flexion which the surgeon was satisfied with.No adverse patient consequences were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC-S 60 REFOBACIN PLUS BO NE CEMENT
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8292446
MDR Text Key134591504
Report Number3006946279-2019-00080
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 10/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2018
Device Model NumberN/A
Device Catalogue Number47215020841
Device Lot NumberA703A07285
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/24/2018
Initial Date FDA Received01/31/2019
Supplement Dates Manufacturer Received09/25/2019
Supplement Dates FDA Received10/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
-
-